title: Serum carnitine levels in patients with homozygous beta thalassemia: a possible new role for carnitine?
abstract: Carnitine (beta-hydroxy-gamma-trimethylaminobutyric acid) facilitates the transfer of activated long-chain fatty acids from the cytoplasm to the mitochondria, the site of their beta-oxidation. Carnitine deficiency results in a reduced usage of fatty acids in energy production and therefore the appearance of clinical symptoms such as myalgia and muscle weakness. In the present study, serum carnitine levels were measured in 45 children and 20 adults with homozygous beta thalassemia. A decrease in serum carnitine levels (total, free and acyl) was found, without any evidence of disorder in the process of mitochondrial beta-oxidation. The possible cause of this finding could be related to a reduced hepatic carnitine biosynthesis.
  
  
  CONCLUSIONS
  In patients with homozygous beta thalassemia, the reduction of serum carnitine levels might play an important role in the appearance of muscular dysfunction. It is possible that L : -carnitine administration in these patients might improve or even resolve the aforementioned symptom.
authors.affiliation: 3rd Department of Paediatrics, "Attikon" University Hospital, University of Athens, Athens, Greece. billtsag@yahoo.com
authors.forename: Vasileios
authors.initials: V
authors.lastname: Tsagris
authors.forename: Georgia
authors.initials: G
authors.lastname: Liapi-Adamidou
mesh_terms: D000293:Adolescent; D000328:Adult; D002331:Carnitine / Q000031:analogs & derivatives* / Q000097:blood* / Q000172:deficiency*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D005227:Fatty Acids / Q000097:blood; D005260:Female; D006720:Homozygote; D006801:Humans; D008297:Male; D018908:Muscle Weakness / Q000209:etiology; D011795:Surveys and Questionnaires; D017086:beta-Thalassemia / Q000097:blood*
chemical_list: D005227:Fatty Acids; C116917:acylcarnitine; D002331:Carnitine
references.citation: Arch Fr Pediatr. 1980 Mar;37(3):173-5
references.pmid: 7469696
references.citation: Neurology. 1975 Jan;25(1):16-24
references.pmid: 234182
references.citation: Clin Chim Acta. 1972 Mar;37:235-43
references.pmid: 5022087
references.citation: Neurology. 1983 Dec;33(12):1629-31
references.pmid: 6685837
references.citation: Science. 1973 Mar 2;179(4076):899-902
references.pmid: 4687787
references.citation: N Engl J Med. 1998 Dec 3;339(23):1712; author reply 1713-4
references.pmid: 9867539
references.citation: Acta Haematol. 1998 Dec;100(3):162-3
references.pmid: 9858797
references.citation: J Clin Invest. 1977 Sep;60(3):716-23
references.pmid: 893675
references.citation: Arch Dis Child. 1987 Nov;62(11):1170-2
references.pmid: 3688923
references.citation: Wien Klin Wochenschr. 1989 Jan 6;101(1):39-44
references.pmid: 2536513
references.citation: J Lipid Res. 1964 Apr;5:184-7
references.pmid: 14174004
references.citation: Pediatr Res. 1990 Sep;28(3):247-55
references.pmid: 2235122
references.citation: Southeast Asian J Trop Med Public Health. 1992;23 Suppl 2:110-5
references.pmid: 1298983
references.citation: Eur J Pediatr. 1988 May;147(4):356-60
references.pmid: 3396591
references.citation: Acta Haematol. 2004;111(3):143-8
references.pmid: 15034235
references.citation: Arch Dis Child. 1996 Jun;74(6):475-8
references.pmid: 8758120
references.citation: Int J Tissue React. 1994;16(3):121-9
references.pmid: 7852033
references.citation: Clin Biochem. 1970 Dec;3(4):315-7
references.pmid: 5527100
references.citation: N Engl J Med. 1993 Jan 14;328(2):81-6
references.pmid: 7677966